Trials / Conditions / Menkes Disease
Menkes Disease
7 registered clinical trials studyying Menkes Disease — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Phase I/II Study of NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease. NCT07398508 | Stephen G. Kaler | Phase 1 / Phase 2 |
| Completed | Baby Detect : Genomic Newborn Screening NCT05687474 | Centre Hospitalier Universitaire de Liege | — |
| Completed | NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Occipital Horn Syndrome NCT04977388 | Stephen G. Kaler, MD | Phase 1 / Phase 2 |
| Active Not Recruiting | Long Term Follow-up on Menkes Disease Patients NCT04337684 | Sentynl Therapeutics, Inc. | — |
| Enrolling By Invitation | Early Check: Expanded Screening in Newborns NCT03655223 | RTI International | — |
| Completed | Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper NCT00811785 | Cyprium Therapeutics, Inc. | Phase 3 |
| Approved For Marketing | Copper Histidinate Treatment for Menkes Disease NCT04074512 | Sentynl Therapeutics, Inc. | — |